Patrick Schöffski | Researchain

Archive Network Publication Hotspot Collaboration

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where Patrick Schöffski is active.

Explore More

Publication

Featured researches published by Patrick Schöffski.

Archive | 2009

Efficacy of IPI-504 “a novel inhibitor of heat shock protein 90” in a preclinical mouse model of gastro intestinal stromal tumor (GIST)

G Floris; Maria Debiec-Rychter; Raf Sciot; Cristiana Stefan; Agnieszka Wozniak; Kathleen Machiels; Emmanuel Normant; Patrick Schöffski

Archive | 2012

A medium-throughput compound screen identifies novel treatment options for gastrointestinal stromal tumors (GIST)

Sergei Boichuk; D.J. Lee; Keith R. Mehalek; Kathleen R. Makielski; Agnieszka Wozniak; Nina Korzeniewski; Rolando Cuevas; James Zewe; S.-F. Kuan; D.S. Sevevaratne; Matthew F. Brown; Takahiro Taguchi; Patrick Schöffski; Maria Debiec-Rychter; Anette Duensing

Abstract book | 2010

Genomic profiling discloses differences in imatinib-resistant gastrointestinal stromal tumors (GIST) with primary KIT exon 9 or KIT exon 11 mutations

Agnieszka Wozniak; P. Rutkowski; Raf Sciot; Julio Finalet Ferreiro; Wanda Michej; Vanspauwen; M Ampe; L Morzuch; W. Ruka; Ivo De Wever; Patrick Schöffski; Maria Debiec-Rychter

Molecular Cancer Therapeutics | 2007

A phase I dose finding study of a 3-day administration of BIBW 2992, an irreversible dual EGFR/HER2 inhibitor, in combination with 3-weekly docetaxel in patients with advanced solid tumors

Patrick Schöffski; Herlinde Dumez; Pascal Wolter; Alain Hendlizs; Tatiana Besse-Hammer; M Piccart; Johan Selleslach; Mehdi Shahidi; Martine Taton; Ahmad Awada

Online abstracts | 2015

Establishment and characterizatoin of a panel of patient-derived soft tissue sarcoma (STS) xenograft models for in vivo testing of novel therapeutic approchaes

Haifu Li; Jasmien Cornillie; Agnieszka Wozniak; Thomas Van Looy; Yemarshet Kelemework Gebreyohannes; Jasmien Wellens; Ulla Vanleeuw; Daphne Hompes; Marguerite Stas; Friedl Sinnaeve; Maria Debiec-Rychter; Raf Sciot; Patrick Schöffski

Online abstracts | 2015

Efficacy of an innovative, enzyme-activated doxorubicin prodrug in patient-derived dedefferentiated liposarcoma and synovial sarcoma xenograft models

Jasmien Cornillie; Agnieszka Wozniak; Lise Vreys; Haifu Li; Thomas Van Looy; Jasmien Wellens; Ulla Vanleeuw; Andre Trouet; Peter Pokreisz; Daphne Hompes; Maria Debiec-Rychter; Raf Sciot; Patrick Schöffski

Online abstracts | 2015

Anti-tumor effects of dovitinib, a multi-target kinase inhibitor, in patient-derived gastrointestinal stromal tumor (GIST) xenograft models

Yemarshet Kelemework Gebreyohannes; Thomas Van Looy; Agnieszka Wozniak; Haifu Li; Jasmien Cornillie; Ulla Vanleeuw; Lise Vreys; Maria Debiec-Rychter; Raf Sciot; Patrick Schöffski

Archive | 2015

PLX9486 shows anti-tumor efficacy in a patient-derived gastrointestinal stromal tumor (GIST) xenograft model resistant to standard tyrosine kinase inhibitors (TKI)

Yemarshet Kelemework Gebreyohannes; Agnieszka Wozniak; Thomas Van Looy; Jasmien Wellens; Jasmien Cornillie; Gaston Habets; Jack Lin; Adhirai Marimuthu; Maria Debiec-Rychter; Raf Sciot; Patrick Schöffski

Archive | 2015

Cabozantinib, a multi-target tyrosine kinase inhibitor, shows anti-tumor efficacy in xenograft models of gastrointestinal stromal tumor (GIST)

Yemarshet Kelemework Gebreyohannes; Agnieszka Wozniak; Jasmien Wellens; Lise Vreys; Jasmien Cornillie; Ulla Vanleeuw; Dana T. Aftab; Maria Debiec-Rychter; Raf Sciot; Patrick Schöffski

Online abstracts | 2014

Cabozantinib, a multi-target receptor tyrosine kinase inhibitor, decreases tumor growth and angiogenesis in a patient-derived dedifferentiated liposarcoma xenograft

Haifu Li; Agnieszka Wozniak; K Van den Bossche; Thomas Van Looy; Jasmien Wellens; Daphne Hompes; Dana T. Aftab; Maria Debiec-Rychter; Raf Sciot; Patrick Schöffski

Explore More